|
Renaissance Technologies bought 1.35 million shares
|
8
|
Mannkind
|
May 15, 2013 04:27PM
|
|
Re: MannKind announces $160M debt financing
|
6
|
Mannkind
|
Jul 01, 2013 12:32PM
|
|
Quantifying Dilution Risk
|
6
|
Mannkind
|
Aug 29, 2012 09:33PM
|
|
Re: Mannkind's Afrezza May Be Half As Effective As Current Injectable Insulins
|
5
|
Mannkind
|
Aug 15, 2013 06:35PM
|
|
Re: Updated Share Price Model
|
5
|
Mannkind
|
Jan 16, 2013 08:30PM
|
|
MannKind Completes Phase 3 Clinical Study of AFREZZA in Patients with Type 2 DM
|
5
|
Mannkind
|
Jun 17, 2013 08:10AM
|
|
Re: New from Novo..
|
5
|
Mannkind
|
Jun 24, 2013 05:21PM
|
|
Re: Call options
|
5
|
Mannkind
|
May 17, 2013 12:36PM
|
|
Re: We need to move forward and figure the best way
|
5
|
Mannkind
|
Aug 16, 2013 09:17AM
|
|
Re: CC Notes / Financing and Partnership Discussion
|
5
|
Mannkind
|
Feb 12, 2013 11:54PM
|
|
Re: MannKind announces $160M debt financing
|
5
|
Mannkind
|
Jul 01, 2013 10:02AM
|
|
Re: Updated Share Price Model
|
4
|
Mannkind
|
Jan 28, 2013 11:52AM
|
|
Re: Valuations
|
4
|
Mannkind
|
Nov 09, 2012 04:08PM
|
|
High Stress Can Make Insulin Cells Regress
|
4
|
Mannkind
|
Oct 02, 2012 08:53PM
|
|
Re: 10-Q
|
4
|
Mannkind
|
Nov 10, 2012 12:55PM
|
|
Re: Quantifying Dilution Risk
|
3
|
Mannkind
|
Sep 02, 2012 12:42PM
|
|
Re: MannKind shares leap as web site says firm is a ripe takeover target
|
3
|
Mannkind
|
May 23, 2013 11:37AM
|
|
Re: Quick update! and we will never see $1.50 again!
|
3
|
Mannkind
|
Sep 21, 2012 04:42PM
|
|
How Exercise Changes Fat and Muscle Cells
|
3
|
Mannkind
|
Jul 31, 2013 01:21PM
|
|
Re: High Stress Can Make Insulin Cells Regress
|
3
|
Mannkind
|
Oct 02, 2012 09:01PM
|
